These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11534826)

  • 1. Chromium(VI) induced alterations in mouse spleen cells: a short-term assay.
    das Neves RP; Santos TM; de Pereira ML; de Jesus JP
    Cytobios; 2001; 106 Suppl 1():27-34. PubMed ID: 11534826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure.
    Finley BL; Kerger BD; Katona MW; Gargas ML; Corbett GC; Paustenbach DJ
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):151-9. PubMed ID: 9007044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the nephrotoxicity and hepatotoxicity of trivalent and hexavalent chromium compounds.
    Dartsch PC; Hildenbrand S; Kimmel R; Schmahl FW
    Int Arch Occup Environ Health; 1998 Sep; 71 Suppl():S40-5. PubMed ID: 9827879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-element distribution profile in Sprague-Dawley rats: effects of intratracheal instillation of Cr(VI) and Zn intervention.
    Song Y; Wang T; Pu J; Guo J; Chen Z; Wang Y; Jia G
    Toxicol Lett; 2014 Apr; 226(2):198-205. PubMed ID: 24560605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of chromium (VI) with macrophages: depletion of glutathione and inhibition of glutathione reductase.
    Lalaouni A; Henderson C; Kupper C; Grant MH
    Toxicology; 2007 Jul; 236(1-2):76-81. PubMed ID: 17498860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of morphological changes in BEAS-2B human bronchial epithelial cells following chronic sub-cytotoxic and mildly cytotoxic hexavalent chromium exposures.
    Costa AN; Moreno V; Prieto MJ; Urbano AM; Alpoim MC
    Mol Carcinog; 2010 Jun; 49(6):582-91. PubMed ID: 20336777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative histological studies on liver of mice exposed to Cr(VI) and Cr(V) compounds.
    das Neves RP; Santos TM; Pereira Mde L; de Jesus JP
    Hum Exp Toxicol; 2002 Jul; 21(7):365-9. PubMed ID: 12269698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses.
    De Flora S; Iltcheva M; Balansky RM
    Mutat Res; 2006 Nov; 610(1-2):38-47. PubMed ID: 16872865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular effects of chromium compound activity].
    Woźniak K
    Postepy Hig Med Dosw; 1996; 50(4):383-94. PubMed ID: 9019747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
    Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA synthesis by chromium compounds.
    Nishio A; Uyeki EM
    J Toxicol Environ Health; 1985; 15(2):237-44. PubMed ID: 3892022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially deadly carcinogenic chromium redox cycle involving peroxochromium(IV) and glutathione.
    Marin R; Ahuja Y; Bose RN
    J Am Chem Soc; 2010 Aug; 132(31):10617-9. PubMed ID: 20681676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice.
    Cheng L; Sonntag DM; de Boer J; Dixon K
    J Environ Pathol Toxicol Oncol; 2000; 19(3):239-49. PubMed ID: 10983890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of Cr(VI) induced oxidative stress, DNA damage and apoptotic cell death in mice.
    Wang XF; Xing ML; Shen Y; Zhu X; Xu LH
    Toxicology; 2006 Nov; 228(1):16-23. PubMed ID: 16979809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice.
    Kirpnick-Sobol Z; Reliene R; Schiestl RH
    Cancer Res; 2006 Apr; 66(7):3480-4. PubMed ID: 16585171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromium(VI) interaction with plant and animal mitochondrial bioenergetics: a comparative study.
    Fernandes MA; Santos MS; Alpoim MC; Madeira VM; Vicente JA
    J Biochem Mol Toxicol; 2002; 16(2):53-63. PubMed ID: 11979422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of nonmutagenic Cr(III)-DNA interactions.
    Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
    Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structures of chromium(VI) complexes with glutathione and model thiols.
    Levina A; Lay PA
    Inorg Chem; 2004 Jan; 43(1):324-35. PubMed ID: 14704084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.